HippoScreen Neurotech Corp.

HippoScreen Neurotech Corp. (HNC) was established in March 2019 by Compal Computer's direct investment in the research team of Professor Liu, Yi-Hung. The company takes EEG signal processing and artificial intelligence technology as the core, aiming to develop EEG-assisted diagnosis and medical services. Its self-developed EEG amplifier cleared FDA 510(k) at the end of 2020, completed the TFDA review, and received approval for the medical device in March 2021, becoming the first medical-grade EEG amplifier manufacturer in Taiwan. In addition, HippoScreen also passed ISO 13485 medical device quality management system certification, received a certificate from BSI in August 2022, and registered to the BSI certification website. Through this professional international standard certification, it is expected that HippoScreen will be able to enter the worldwide market as soon as possible.